How much of the deprivation gap in cancer survival can be explained by variation in stage at diagnosis: An example from breast cancer in the East of England

International Journal of Cancer

Volumn 133, Issue 9, 2013, Pages 2192-2200

  Rutherford, M J ^a   Hinchliffe, S R ^a   Abel, G A ^b   Lyratzopoulos, G ^b   Lambert, P C ^a,c   Greenberg, D C ^b,d  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c KAROLINSKA INSTITUTE   (Sweden)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

avoidable deaths; excess mortality models; relative survival; socioeconomic differences

Indexed keywords

ADULT; ADVANCED CANCER; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PREVENTION; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; PRIORITY JOURNAL; SOCIAL DISCRIMINATION; SOCIAL ISOLATION; SOCIAL STATUS; UNITED KINGDOM;

AVOIDABLE DEATHS; EXCESS MORTALITY MODELS; RELATIVE SURVIVAL; SOCIOECONOMIC DIFFERENCES;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SOCIAL CLASS; SOCIOECONOMIC FACTORS; SURVIVAL RATE;

EID: 84882730721     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28221     Document Type: Article

References (37)

1. Coleman M, Babb P, Damiecki P, et al. Cancer survival trends in England and Wales, 1971-1995: deprivation and NHS region. London: Series SMPS No. 61. London: The Stationery Office, 1999.
2. Coleman M, Babb P, Sloggett A, et al. Socioeconomic inequalities in cancer survival in England and Wales. Cancer 2001; 91: 208-16.
3. Coleman MP, Rachet B, Woods LM, et al. Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001. Br J Cancer 2004; 90: 1367-73.
4. Rachet B, Woods LM, Mitry E, et al. Cancer survival in England and Wales at the end of the 20th century. Br J Cancer 2008; 99 (Suppl 1): S2-S10.
5. Rachet B, Ellis L, Maringe C, et al. Socioeconomic inequalities in cancer survival in England after the NHS cancer plan. Br J Cancer 2010; 103: 446-53.
6. Lyratzopoulos G, Barbiere JM, Rachet B, et al. Changes over time in socioeconomic inequalities in breast and rectal cancer survival in England and Wales during a 32-year period (1973-2004): the potential role of health care. Ann Oncol 2011; 22: 1661-6.
7. Lyratzopoulos G, Abel GA, Brown CH, et al. Socio-demographic inequalities in stage of cancer diagnosis: evidence from patients with female breast, lung, colon, rectal, prostate, renal, bladder, melanoma, ovarian and endometrial cancer. Ann Oncol 2013; 24: 843-50.
8. Richards MA,. The size of the prize for earlier diagnosis of cancer in England. Br J Cancer 2009; 101: S125-S129.
9. Abdel-Rahman M, Stockton D, Rachet B, et al. What if cancer survival in Britain were the same as in Europe: how many deaths are avoidable? Br J Cancer 2009; 101: S115-S124.
10. Pokhrel A, Martikainen P, Pukkala E, et al. Education, survival and avoidable deaths in cancer patients in Finland. Br J Cancer 2010; 103: 1109-14.
11. Lambert PC, Holmberg L, F Sandin, et al. Quantifying differences in breast cancer survival between England and Norway. Cancer Epidemiol 2011; 35: 526-33.
12. Ellis L, Coleman MP, Rachet B,. How many deaths would be avoidable if socioeconomic inequalities in cancer survival in England were eliminated? A national population-based study, 1996-2006. Eur J Cancer 2012; 48: 270-8.
13. Adams J, White M, Forman D,. Are there socioeconomic gradients in stage and grade of breast cancer at diagnosis? Cross sectional analysis of UK cancer registry data. BMJ 2004; 329.
14. Wishart GC, Greenberg DC, Chou P, et al. Treatment and survival in breast cancer in the Eastern Region of England. Ann Oncol 2010; 21: 291-6.
15. Sobin LH, Fleming ID,. TNM classification of malignant tumors, fifth edition (1997). Cancer 1997; 80: 1803-4.
16. Neighbourhood Renewal Unit. The English indices of deprivation 2004 (revised) Office for the Deputy Prime Minister, London, 2004.
17. Lyratzopoulos G, Abel GA, Barbiere JM, et al. Variation in advanced stage at diagnosis of lung and female breast cancer in an English region 2006-2009. Br J Cancer 2012; 106: 1068-75.
18. Nelson CP, Lambert PC, Squire IB, et al. Flexible parametric models for relative survival, with application in coronary heart disease. Stat Med 2007; 26: 5486-98.
19. Elliss-Brookes L, McPhail S, Ives A, et al. Routes to diagnosis for cancer-determining the patient journey using multiple routine data sets. Br J Cancer 2012; 107: 1220-6.
20. Cancer Research UK Cancer Survival Group. Life tables for cancer survival analysis. Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, UK, 2006. Available at: www.lshtm.ac.uk/ncde/ cancersurvival/tools.
21. Ederer F, Axtell L, Cutler SJ,. The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr 1961; 6: 101-21.
22. Seppa K, Hakulinen T, Laara E,. Avoidable deaths and random variation in patients' survival. Br J Cancer 2012; 106: 1846-9.
23. StataCorp. Stata statistical software: release 12. College Station, TX: StataCorp LP, 2011.
24. Lambert PC, Holmberg L, Sandin F, et al. Quantifying differences in breast cancer survival between England and Norway. Cancer Epidemiol 2011; 35: 526-33.
25. Department of Health. Delivering the Cancer Reform Strategy. Report by the Comptroller and Auditor General. Technical Report, HC 568, Session 2010-2011.
26. Department of Health. Improving outcomes: a strategy for cancer. Technical Report, London, 2011.
27. Rubin G, Elliott K, McPhail S, National Audit of Cancer Diagnosis in Primary Care. Royal College of General Practitioners (2011) http://www.rcgp.org. uk/pdf/National-Audit-of-Cancer-Diagnosis-in-Primary-Care.pdf. last accessed May, 2013.
28. Lyratzopoulos G, Neal RD, Barbiere JM, et al. Variation in number of general practitioner consultations before hospital referral for cancer: findings from the 2010 National Cancer Patient Experience Survey in England. Lancet Oncol 2012; 13: 353-65.
29. Lyratzopoulos G, Abel G, McPhail S, et al. Measures of promptness of cancer diagnosis in primary care: secondary analysis of national audit data on patients with 18 common and rarer cancers. Br J Cancer 2013; 108: 686-90.
30. Robb K, Stubbings S, Ramirez A, et al. Public awareness of cancer in Britain: a population-based survey of adults. Br J Cancer 2009; 101: S18-S23.
31. Beeken RJ, Simon AE, von Wagner C, et al. Cancer fatalism: deterring early presentation and increasing social inequalities? Cancer Epidemiol Biomarkers Prev 2011; 20: 2127-31.
32. Forbes LJL, Linsell L, Atkins L, et al. A promoting early presentation intervention increases breast cancer awareness in older women after 2 years: a randomised controlled trial. Br J Cancer 2011; 105: 18-21.
33. Lyratzopoulos G, Greenberg DC, Rubin GP, et al. Advanced stage diagnosis of cancer: who is at greater risk? Expert Rev Anticancer Ther 2012; 12: 993-6.
34. Cuthbertson SA, Goyder EC, Poole J,. Inequalities in breast cancer stage at diagnosis in the Trent region, and implications for the NHS Breast Screening Programme. J Public Health 2009; 31: 398-405.
35. Shen Y, Yang Y, Inoue LYT, et al. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials. J Natl Cancer Inst 2005; 97: 1195-203.
36. Walters S, Maringe C, Butler J, et al. Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study. Br J Cancer 2013; 108: 1195-208.
37. Walters S, Maringe C, Coleman MP, et al.; the I. C. B. P Module 1 Working Group. Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004-2007. Thorax 2013. [Epub ahead of print].